| 000 | 01699 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516144746.0 | ||
| 264 | 0 | _c20130618 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a2168-619X | ||
| 024 | 7 |
_a10.1001/jamaoto.2013.214 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCohen, Stephanie M | |
| 245 | 0 | 0 |
_aEfficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma. _h[electronic resource] |
| 260 |
_bJAMA otolaryngology-- head & neck surgery _cApr 2013 |
||
| 300 |
_a382-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNeoplasms, Experimental |
| 650 | 0 | 4 | _aSquamous Cell Carcinoma of Head and Neck |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Burden |
| 700 | 1 | _aRockefeller, Nick | |
| 700 | 1 | _aMukerji, Ridhwi | |
| 700 | 1 | _aDurham, Dianne | |
| 700 | 1 | _aForrest, M Laird | |
| 700 | 1 | _aCai, Shuang | |
| 700 | 1 | _aCohen, Mark S | |
| 700 | 1 | _aShnayder, Yelizaveta | |
| 773 | 0 |
_tJAMA otolaryngology-- head & neck surgery _gvol. 139 _gno. 4 _gp. 382-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamaoto.2013.214 _zAvailable from publisher's website |
| 999 |
_c22681827 _d22681827 |
||